Compare Globus Medical Inc. Class A Common Stock (GMED) vs PayPal Holdings, Inc. (PYPL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globus Medical Inc. Class A Common Stock vs PayPal Holdings, Inc. — how do they compare? Globus Medical Inc. Class A Common Stock trades at $77.92 (market cap $10.25B), while PayPal Holdings, Inc. trades at $56.02 (market cap $47.99B). The key difference: PayPal Holdings, Inc. is far larger — about 4.7× Globus Medical Inc. Class A Common Stock's market cap, and PayPal Holdings, Inc. pays a 1% dividend while Globus Medical Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and PayPal Holdings, Inc. for 106 Days on average.
| GMED | PYPL | |
|---|---|---|
Market Cap | $10.25B | $47.99B |
Volume | 1,059,528 | 9,873,263 |
Sector | Health | Financials |
52-Week High | $96.82 | $73.01 |
52-Week Low | $58.33 | $39.08 |
Typical Hold Time | 0 Days | 106 Days |
Enterprise Value | $9.76B | $50.14B |
Dividend Yield | — | 1% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
PayPal (PYPL) trades at $56.17, up 0.21% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $56.41. The company reported revenue of $33.17B in 2025, with net income of $5.23B and strong profitability metrics, including a 14.36% net margin. Recent news highlights a partnership with Meta's Muse AI agent, potentially boosting checkout capabilities.
PYPL presents a value opportunity with a low P/E of 10.6 and solid cash flow, but faces risks from competitive pressures in digital payments and investor skepticism reflected in a majority hold rating. Upside depends on successful execution of new initiatives under CEO Enrique Lores.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →About PayPal Holdings, Inc.
PayPal Holdings, Inc. operates as a technology platform company that enables digital and mobile payments on behalf of consumers and merchants. The Company offers online payment solutions. PayPal Holdings serves customers worldwide.
Read more on PYPL →
